Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study

• Váldodahkkit: Heidar Sharafi (Dahkki), Seyed Hoda Alavian (Dahkki), Bita Behnava (Dahkki), Mohammad Saeid Rezaee-Zavareh (Dahkki), Mehri Nikbin (Dahkki), Seyed Moayed Alavian (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Babol University of Medical Sciences, 2020-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Treatment of hepatitis C virus (HCV) infection with recently introduced direct-acting antiviral agents (DAA) is effective and safe, however there is little known regarding safety and efficacy of generic DAAs in the real-life clinical setting. This study aimed to evaluate the efficacy and...